The Biotech Growth Trust (BIOG) is managed by Geoff Hsu, who is able to draw on the considerable resources of specialist healthcare investor OrbiMed Capital. While biotech stocks have rallied strongly following the coronavirus-led stock market sell-off earlier in 2020, the manager believes they could have further to go. He is confident that a successful COVID-19 vaccine will be developed and positive fundamentals are supportive for the biotech sector’s future performance. Repositioning
10 Aug 2020
The Biotech Growth Trust - Firing on all cylinders
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
The Biotech Growth Trust - Firing on all cylinders
Biotech Growth Trust PLC (BIOG:LON) | 956 86.1 0.9% | Mkt Cap: 319.6m
- Published:
10 Aug 2020 -
Author:
Mel Jenner -
Pages:
10
The Biotech Growth Trust (BIOG) is managed by Geoff Hsu, who is able to draw on the considerable resources of specialist healthcare investor OrbiMed Capital. While biotech stocks have rallied strongly following the coronavirus-led stock market sell-off earlier in 2020, the manager believes they could have further to go. He is confident that a successful COVID-19 vaccine will be developed and positive fundamentals are supportive for the biotech sector’s future performance. Repositioning